Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 503 clinical trials
featured
A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)

  • 370 views
  • 25 Mar, 2021
  • 1 location
featured
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

  • 264 views
  • 25 Mar, 2021
  • 1 location
featured
Washington University seeks participants with major depression for a research study.

Washington University seeks participants with major depression for a research study.

  • 2106 views
  • 25 Mar, 2021
  • 1 location
featured
A Research Study is being conducted to evaluate an investigational product to be used for the treatment of Major Depressive Disorder (or MDD) in women. Qualified participants receive study-related care, and exams at no charge.

A Research Study is being conducted to evaluate an investigational product to be used for the treatment of Major Depressive Disorder (or MDD) in women. Qualified participants receive study-related

  • 924 views
  • 08 Nov, 2020
  • 1 location
featured
A Two-Part Study of CLE-100 as an Adjunct Therapy in Subjects With Major Depressive Disorder

The pharmaceutical company Clexio is studying an investigational drug called CLE-100 and its effectiveness in treatment of major depressive disorder (MDD) symptoms. This Study has two parts

  • 2 views
  • 05 Apr, 2021
  • 1 location
featured
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

A Randomized, Double-blind, Placebo-controlled, Multicenter Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder

  • 532 views
  • 25 Mar, 2021
  • 1 location
featured
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder

  • 656 views
  • 25 Mar, 2021
  • 1 location
featured
A phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants with Major Depressive Disorder

Praxis Precision Medicines is developing PRAX-114 (the study drug) as a possible new treatment for depression.Depression is a common but serious mood disorder. It causes severe symptoms that affect how you feel, think, and handle daily activities. Common symptoms of depression can include persistent feelings of sadness and loss of …

mood disorder
depressed mood
depressive symptoms
  • 0 views
  • 24 May, 2021
  • 1 location
featured
A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients With Major Depressive Disorder

  • 94 views
  • 25 Mar, 2021
  • 1 location
featured
A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Adolescent Patients with Major Depressive Disorder

  • 182 views
  • 08 Nov, 2020
  • 1 location